Mitigation of biochemical alterations in streptozotocin‐induced gestational diabetes in rats through mesenchymal stem cells and olive leaf extract

Abstract

Treatment with mesenchymal stem cells (MSCs) is a new promising therapeutic approach with substantial very auspicious potential. They have been shown to protect various played a role in protecting organs from damage. This current study aims to evaluate the impact of the treatment of olive leaf extract (OLE), bone marrow‐derived (BM‐MSCs), and their combination on hepatotoxicity in pregnant rats with diabetes. Methods: Animals were divided into five groups (10 pregnant rats each) as follows: control, GDM group, and OLE group (rats received streptozotocin (STZ) at a dose of 35 mg/kg body weight). GD + OLE set (pregnant rats were administered OLE at a dose of 200 mg extract/kg of body weight). GD + MSCs group (pregnant rats treated with MSCs). GD + OLE + MSCs group (pregnant rats were treated with both MSCs and OLE). Results: STZ induced significant changes in liver parameters, lipid profile, and oxidative stress. Treatment with OLE, BM‐MSCs, and their combination significantly ameliorated STZ‐induced liver damage and oxidative stress. STZ resulted in a significant change in liver parameters, lipid profile, and oxidative stress. OLE, BM‐MSC, and combination have significantly improved STZ‐induced deterioration in liver and improved oxidative stress. Conclusions: The findings demonstrate that OLE and BM‐MSCs have beneficial effects in mitigating diabetes‐related liver alterations. These outcomes showed that OLE and BM‐MSC have beneficial effects in alleviating diabetes‐related alterations in the liver.